← Back to Clinical Trials
Recruiting NCT07522398

NCT07522398 Acute Power Training Effects in Older Adults

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07522398
Status Recruiting
Phase
Sponsor Hasselt University
Condition Muscle Power
Study Type INTERVENTIONAL
Enrollment 42 participants
Start Date 2026-04-20
Primary Completion 2027-01

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age 85 Years
Study Type INTERVENTIONAL
Interventions
Power Training at Different Fatigue Levels

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 42 participants in total. It began in 2026-04-20 with a primary completion date of 2027-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to learn how older adults respond to power training when the level of fatigue during exercise is different. Power training means performing fast movements with moderate loads to improve strength, power and mobility. The main questions the study aims to answer are: * How does the level of fatigue during power training acutely affect strength, movement, and muscle function? * How does it affect recovery, muscle soreness, and how hard the exercise feels? Researchers will compare three power-training sessions with different fatigue levels to see which approach may be safest and most effective for older adults. Participants will be healthy older adults aged 65 to 85 years. Each participant will complete three supervised exercise sessions on a leg press machine. The sessions will take place about one week apart. During the study, participants will: * Perform power training on a pneumatic leg press machine * Complete strength and mobility tests before and after exercise * Provide small blood samples to measure body responses to exercise * Rate how hard the exercise feels * Report muscle soreness for up to two days after exercise The results may help researchers design safer and more effective power-training programs to improve strength, mobility, and recovery in older adults.

Eligibility Criteria

Inclusion criteria: Participants must: * Be 65 to 85 years old. * Be able to live independently and perform everyday activities without help. * Not have regularly done resistance or strength training in the past year. * Be able to understand study instructions and communicate in the study language. * Have a recent statement from their treating physician confirming that their heart and blood vessels are healthy enough to safely take part in this study. Exclusion criteria Participants will not be eligible if they have any of the following: * Unstable heart disease, neurological disease, acute infection, or fever. * Use of non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, in the 5 days before the study. * Use of whey protein, casein, or amino acid supplements in the month before the study. * Acute or chronic injuries to the legs or lower body muscles. * Any injury or condition that prevents safe leg extension exercises. * Recent lower-limb joint replacement (less than 6 months ago). * Dependence on walking aids. * Current participation in another interventional trial.

Contact & Investigator

Central Contact

Max Riesbeck, Master of Science

✉ max.riesbeck@uhasselt.be

📞 +32 11 26 84 93

Principal Investigator

Evelien Van Roie, PhD

PRINCIPAL INVESTIGATOR

Hasselt University, Faculty of Rehabilitation Sciences

Frequently Asked Questions

Who can join the NCT07522398 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, up to 85 Years, studying Muscle Power. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07522398 currently recruiting?

Yes, NCT07522398 is actively recruiting participants. Contact the research team at max.riesbeck@uhasselt.be for enrollment information.

Where is the NCT07522398 trial being conducted?

This trial is being conducted at Diepenbeek, Belgium.

Who is sponsoring the NCT07522398 clinical trial?

NCT07522398 is sponsored by Hasselt University. The principal investigator is Evelien Van Roie, PhD at Hasselt University, Faculty of Rehabilitation Sciences. The trial plans to enroll 42 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology